Letters to the Editor

Do liberal thresholds for red cell transfusion result in improved quality of life for patients undergoing intensive chemotherapy for acute myeloid leukemia? A randomized cross over feasibility study

Department of Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom. B15 2WB; Medical Department, NHS Blood and Transplant, Birmingham, United Kingdom. B15 2SG
Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom. NW1 2BU; Royal Free London NHS Foundation Trust, Department of Haematology, London, United Kingdom. NW3 2QG
Clinical Trials Unit, NHS Blood and Transplant, Cambridge, United Kingdom. CB2 0PT
Clinical Trials Unit, NHS Blood and Transplant, Cambridge, United Kingdom. CB2 0PT
Clinical Trials Unit, NHS Blood and Transplant, Cambridge,
Clinical Trials Unit, NHS Blood and Transplant, Bristol,
Clinical Trials Unit, NHS Blood and Transplant, Bristol, United Kingdom. BS34 8RR
Clinical Trials Unit, NHS Blood and Transplant, Cambridge, United Kingdom. CB2 0PT
Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom. OX3 9BQ; Clinical Department, NHS Blood and Transplant, Oxford, United Kingdom. OX3 9BQ; Radcliffe Department of Medicine, University of Oxford, and NIHR Oxford Biomedical Research Centre
Haematologica Early view Feb 24, 2022 https://doi.org/10.3324/haematol.2021.279867